Skip Ribbon Commands
Skip to main content
Clin Asst Prof Chia Seng Hup Brendan

Clin Asst Prof Chia Seng Hup Brendan

​MB ChB BAO (Ireland), FRCR (Clinical Oncology)


National Cancer Centre Singapore

Specialty: Radiation Oncology

Clinical Interest: Thoracic-Oncology, Neuro-Oncology, Radiosurgery, Radiotherapy

Conditions Treated by this Doctor:
Brain cancer, Lung Cancer, Radiosurgery, Stereotactic Radiotherapy, Thoracic Cancers.

Clinical Appointments

  • Consultant Division of Radiation Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore

Academic Appointments

  • Clinical Asst Professor at Duke-NUS Medical School


​Dr Chia is a Consultant Radiation Oncologist, with subspecialty interest in Lung and Brain Cancers as well as Stereotactic Body Radiotherapy and Stereotactic Radiosurgery.

In 2016, Dr Chia completed his training specialty training and obtained is fellowship in Clinical Oncology from the Royal College of Radiologist, UK. He concurrent had completed his Masters in Clinical Investigation for performing biomarker research in Lung cancer. Subsequent to this he obtained SingHealth Overseas Training Award in 2016 where he trained in St. Bartholomew's Hospital, UK for a year in Lung and Brain Clinical Oncology as well as CyberKnife applications.

Dr Chia is interested in improving patients outcomes and is actively involved in research related to both lung and brain radiotherapy. He is involved in teaching medical students, nurses, radiotherapy staff and residents. He is also certified to perform Stereotactic Body Radiotherapy to Lung and bone lesions as well as perform Stereotactic Radiosurgery for brain lesions.


  • ​FRCR Clinical Oncology (UK) 2016
  • MCI (Singapore) 2016
  • MB ChB BAO (Ireland) 2010

Professional Appointments and Committee Memberships

  • Consultant. Department of Radiation Oncology, NCCS 2019 – present
  • EXCO Member, Singapore Radiological Society 2017-present
  • Member, Code Blue Committee, NCCS 2018-present


  • ​Masters of Clinical Investigation NMRC Sponsorship, 2013
  • SingHealth Overseas Training Award 2016

Research Interests

  • ​Lung Radiotherapy
  • Biomarkers in Lung Cancer
  • Brain Metastases Management


  • ​Thoracic intervention and surgery to cure lung: an overview of stereotactic ablative radiotherapy in early and oligometastatic lung cancer. J R Soc Med. 0(0) 1-7 2018 Jan 1:141076818763334.
  • Study protocol for the SARON trial: a multicentre,randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer. Conibear J, Chia B, Ngai Y, et al. BMJ Open. 2018 Apr 17;8(4):e020690.
  • Pitfalls in lung stereotactic body radiotherapy—a review of organ toxicities and dose constraints. Chia B and Zubin M. J Xiangya Med 2018;3:36. doi: 10.21037/jxym.2018.09.04

Research Trials

  • Treatment outcomes in Lung Radiotherapy
  • CPAP use for Simulation in Radical Lung Radiotherapy
  • Hippocampal Whole brain radiotherapy with or without Simultaneous intergrated boost in the management if multiple brain metastases.